منابع مشابه
Nasal septum extramedullary plasmacytoma.
INTRODUCTION Plasmacytomas are malignant tumors characterized by abnormal monoclonal proliferation of plasma cells. They originate in either bone--solitary osseous plasmacytoma, or in soft tissue--extramedullary plasmacytoma (EMP). EMP represents less than 1% of all head and neck malignancies. CASE REPORT We presented a case of EMP of the nasal septum in a 44-year-old male who had progressive...
متن کاملExtramedullary plasmacytoma arising from the nasal septum.
We report a rare case of extramedullary plasmacytoma of the nasal septum in a 65-year-old woman. She presented with a 2-month history of left-sided nasal obstruction and intermittent blood-tinged nasal crusting. Nasal endoscopy revealed that a dark-red mass had arisen from the nasal septum; no evidence of invasion to adjacent tissues was seen. A biopsy specimen was diagnosed as a plasmacytoma (...
متن کاملExtramedullary plasmacytoma of the nasal cavity.
Extramedullary plasmocytoma occurs in the nasal cavity relatively rarely. Basing upon the case of a 59-year old woman, the authors discuss the difficulties of diagnostic treatment and the course of the disease.
متن کاملExtramedullary nasal plasmacytoma: Literature review and a rare case report
INTRODUCTION Extramedullary plasmacytoma is a plasma cell tumor that grows within any of the soft tissues of the organism. Similar to all plasmacytic dyscrasia, the disease is extremely rare. AIM This study reports a case of an extramedullary plasmacytoma of the nasal cavity and provides a literature review on the topic. CASE REPORT A 51-year-old woman presented at our tertiary universit...
متن کاملMultiple primary cutaneous plasmacytoma a decade after a nasal solitary extramedullary plasmacytoma: a puzzling case
Primary cutaneous plasmacytoma should be in the differential diagnosis in case of solitary or multiple erythematous-violaceous nodules or papules. The diagnosis relies on clinical, histological, and immunochemical findings, without underlying evidence of multiple myeloma. Treatment should be individualized, and agents such as bortezomib or lenalidomide have shown to be effective.
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Military Medical and Pharmaceutical Journal of Serbia
سال: 2013
ISSN: 0042-8450,2406-0720
DOI: 10.2298/vsp1302221b